Status:
COMPLETED
Metastatic Colorectal Cancer. Real-World Data Analysis.
Lead Sponsor:
Istanbul Medeniyet University
Conditions:
Metastatic Colorectal Cancer
Eligibility:
All Genders
18-99 years
Brief Summary
The Treatment Choices, Duration and Outcomes in Patients with Ras Wild Type (RAS WT) Metastatic Colorectal Cancer (mCRC). Retrospective, Multi-Center, Real-World Data Analysis
Detailed Description
In this study, with the given rationale is to reveal treatment approaches, survival data, side effect profile and their management in our country in RAS WT mCRC patients by means of the real-world dat...
Eligibility Criteria
Inclusion
- Patients who have been histologically diagnosed with mCRC
- Patients over the age of 18
- Patients receiving at least a cycle systemic treatment for metastatic disease
- RAS wild type patients
- Patients who has demographic, histopathological and clinical information
Exclusion
- Patients diagnosed as mCRC but only referred to BSC
- Patients with RAS mutation
- Patients who were included in any clinical trial except standard treatments during their treatment
Key Trial Info
Start Date :
August 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
1750 Patients enrolled
Trial Details
Trial ID
NCT04757311
Start Date
August 1 2020
End Date
October 1 2021
Last Update
October 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul Medeniyet University Hospital
Istanbul, Turkey (Türkiye), 81450